Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Clinicoeconomics and Outcomes Research : CEOR|January 1, 2016
Adjustment of foreign EQ-5D-3L utilities can increase their transferabilityLars Oddershede, Karin Dam PetersenDanish Medical Journal|May 13, 2014
In Denmark kidney transplantation is more cost-effective than dialysisCathrine Elgaard Jensen, Preben Sørensen, Karin Dam PetersenSpine|February 23, 2013
Cost-effectiveness and cost-benefit analyses of a multidisciplinary intervention compared with a brief intervention to facilitate return to work in sick-listed patients with low back painChris Jensen, Claus Vinther Nielsen, Ole Kudsk Jensen, et al.BMJ Open|June 9, 2016
Systematic review of the cost-effectiveness of implementing guidelines on low back pain management in primary care: is transferability to other countries possible?Cathrine Elgaard Jensen, Martin Bach Jensen, Allan Riis, et al.Journal of Medical Economics|April 30, 2013
Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwideLouise Justesen Hesselbjerg, Heidi Sjoelund Pedersen, Mikael Bergholdt Asmussen, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 22, 2013
Asthma from the patient's perspectiveAbir Al-kalemji, Helle Johannesen, Karin Dam Petersen, et al.The Patient|July 7, 2017
Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQL<sup>TM</sup> 4.0 Short Form 15Karin Dam Petersen, Gang Chen, Christine Mpundu-Kaambwa, et al.Implementation Science : IS|October 9, 2014
Study protocol of an economic evaluation of an extended implementation strategy for the treatment of low back pain in general practice: a cluster randomised controlled trialCathrine Elgaard Jensen, Allan Riis, Kjeld Møller Pedersen, et al.Pain|January 24, 2017
Economic evaluation of an implementation strategy for the management of low back pain in general practiceCathrine Elgaard Jensen, Allan Riis, Karin Dam Petersen, et al.Pharmacoeconomics|December 9, 2016
Mapping CHU9D Utility Scores from the PedsQL<sup>TM</sup> 4.0 SF-15Christine Mpundu-Kaambwa, Gang Chen, Remo Russo, et al.Pageof 2